tradingkey.logo
搜尋

iSpecimen Inc

ISPC
添加自選
1.880USD
+0.050+2.73%
收盤 07-31 16:00美東報價延遲15分鐘
34.85K總市值
虧損本益比TTM

關於 iSpecimen Inc 公司

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc簡介

公司代碼ISPC
公司名稱iSpecimen Inc
上市日期Jun 17, 2021
CEOField (Katharyn)
員工數量24
證券類型Ordinary Share
年結日Jun 17
公司地址8 Cabot Road
城市WOBURN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編08101
電話17813016700
網址https://www.ispecimen.com/
公司代碼ISPC
上市日期Jun 17, 2021
CEOField (Katharyn)

iSpecimen Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

常見問題

iSpecimen Inc的前五大股東是誰?

iSpecimen Inc的前五大股東如下:Mr. Avtar Dhaliwal

有多少機構持有iSpecimen Inc(ISPC)的股份?

截至2026Q1,共有31家機構持有iSpecimen Inc的股份,合計持有的股份價值約為5.11K,占公司總股份的0.39% 。與2025Q4相比,機構持股有所增加,增幅為-79730.00。

哪個業務部門對iSpecimen Inc的收入貢獻最大?

在2026Q1,Specimens – contracts with customers業務部門對iSpecimen Inc的收入貢獻最大,創收95.82K,占總收入的89.89% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有